Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant-Reference-Cited by-同舟云学术

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

Published:2016-07 Issue:7 Volume:22 Page:1324-1329
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Motabi Ibraheem H.,Ghobadi Armin^ORCID,Liu Jingxia,Schroeder Mark,Abboud Camille N.,Cashen Amanda F.,Stockler-Goldstein Keith E.,Uy Geoffrey L.,Vij Ravi,Westervelt Peter,DiPersio John F.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference21 articles.

1. Relapse after allogeneic stem cell transplantation;Barrett;Exp Rev Hematol,2010

2. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant;Shaw;Bone Marrow Transplant,2008

3. A retrospective review of the outcome after second or subsequent allogeneic transplantation;Kedmi;Biol Blood Marrow Transplant,2009

4. Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia;Hosing;Bone Marrow Transplant,2005

5. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant;Eapen;Bone Marrow Transplant,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34+ and CD3+ donor chimerism (DC) monitoring;Leukemia Research;2024-07

2. Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant;Clinical Lymphoma Myeloma and Leukemia;2024-06

3. How I reduce and treat posttransplant relapse of MDS;Blood;2024-04-04

4. Donor lymphocyte infusion in Acute Myeloid Leukemia;Best Practice & Research Clinical Haematology;2023-09

5. Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis;BMC Cancer;2023-08-17